CLINICAL_TRIALS
trial_result
· 2017-10-19
Clinical Trial Update: Mirvaso in Use Study [Phase 4]
Summary
Phase 4 clinical trial update for Mirvaso (brimonidine) in rosacea has completed; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Rosacea | Phase 4 | Status: COMPLETED | Results posted: 2017-10-19